Denmark· DK-28107271024
Ryaltris
A mometason, kombinationen product containing mometasonfuroat monohydrat, olopatadinhydrochlorid, registered in Denmark by Orifarm A/S. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Mometason, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AD59 (mometason, kombinationen), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Mometason, kombinationen · ATC R01AD59
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Mometasonfuroat monohydrat, OLOPATADINHYDROCHLORID
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- R01AD59
- ATC class
- Mometason, Kombinationen
- Defined daily dose
- 0.2 mg, N
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107271024
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R01AD59
Mometason, kombinationen, as other registers publish it.
- PolandRyaltrisGlenmark Pharmaceuticals s.r.o.
- PolandRyaltrisInPharm Sp. z o.o.
- PolandRyaltrisMedezin Sp. z o.o.
- DenmarkRyaltrisGlenmark Pharmaceuticals s.r.o.
- FinlandRyaltrisGlenmark Pharmaceuticals s.r.o.
- DenmarkRyaltrisParanova Danmark ApS
- PolandRyaltrisMedezin Sp. z o.o.
- PolandRyaltrisInPharm Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdbc4904-4f8a-472c-a595-97849b010367 GET /v1/drugs/fdbc4904-4f8a-472c-a595-97849b010367?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "næsespray, suspension",
"source": "dkma",
"strength": "25+600 mikrog./dosis",
"auth_role": "DKMA",
"dk_drugid": "28107271024",
"substance": "Mometasonfuroat monohydrat, OLOPATADINHYDROCHLORID",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45632"
}See everything about mometason, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.